| A review of chitosan and its derivatives in bone tissue engineering R LogithKumar, A KeshavNarayan, S Dhivya, A Chawla, S Saravanan, ... Carbohydrate polymers 151, 172-188, 2016 | 597 | 2016 |
| Proliferation and differentiation of mesenchymal stem cells on scaffolds containing chitosan, calcium polyphosphate and pigeonite for bone tissue engineering S Dhivya, A Keshav Narayan, R Logith Kumar, S Viji Chandran, ... Cell proliferation 51 (1), e12408, 2018 | 74 | 2018 |
| Carbon nanomaterials for cardiovascular theranostics: Promises and challenges KN Alagarsamy, S Mathan, W Yan, A Rafieerad, S Sekaran, H Manego, ... Bioactive Materials 6 (8), 2261-2280, 2021 | 55 | 2021 |
| Fabrication of Smart Tantalum Carbide MXene Quantum Dots with Intrinsic Immunomodulatory Properties for Treatment of Allograft Vasculopathy A Rafieerad, W Yan, KN Alagarsamy, A Srivastava, N Sareen, RC Arora, ... Advanced Functional Materials, 2106786, 2021 | 53 | 2021 |
| Application of injectable hydrogels for cardiac stem cell therapy and tissue engineering KN Alagarsamy, W Yan, A Srivastava, V Desiderio, S Dhingra Reviews in cardiovascular medicine 20 (4), 221-230, 2019 | 36 | 2019 |
| Proteasomal degradation of TRAF2 mediates mitochondrial dysfunction in doxorubicin-cardiomyopathy R Dhingra, I Rabinovich-Nikitin, S Rothman, M Guberman, H Gang, ... Circulation 146 (12), 934-954, 2022 | 31 | 2022 |
| The role of autophagy in the metabolism and differentiation of stem cells M Adelipour, LR Saleth, S Ghavami, KN Alagarsamy, S Dhingra, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1868 (8), 166412, 2022 | 22 | 2022 |
| Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases GL Sequiera, A Srivastava, N Sareen, W Yan, KN Alagarsamy, E Verma, ... Science Advances 8 (14), eabl4370, 2022 | 16 | 2022 |
| Hypoxia-induced shift in the phenotype of proteasome from 26S toward immunoproteasome triggers loss of immunoprivilege of mesenchymal stem cells E Abu-El-Rub, N Sareen, W Yan, KN Alagarsamy, A Rafieerad, ... Cell Death & Disease 11 (6), 419, 2020 | 16 | 2020 |
| Immunoengineered MXene nanosystem for mitigation of alloantigen presentation and prevention of transplant vasculopathy W Yan, A Rafieerad, KN Alagarsamy, LR Saleth, RC Arora, S Dhingra Nano Today 48, 101706, 2023 | 12 | 2023 |
| Generation and evaluation of isogenic iPSC as a source of cell replacement therapies in patients with Kearns Sayre syndrome G Lester Sequiera, A Srivastava, KN Alagarsamy, C Rockman-Greenberg, ... Cells 10 (3), 568, 2021 | 12 | 2021 |
| Green tea polyphenols in cardiometabolic health: A critical appraisal on phytogenomics towards personalized green tea L Rajan, A Radhakrishnan, KN Alagarsamy, A Srivastava, S Dhingra, ... PharmaNutrition 20, 100296, 2022 | 10 | 2022 |
| Generation of human induced pluripotent stem cell (hiPSC) line UOMi005-A from PBMCs of a patient with Kearns-Sayre syndrome A Srivastava, GL Sequiera, KN Alagarsamy, C Rockman-Greenberg, ... Stem Cell Research 53, 102283, 2021 | 8 | 2021 |
| Stem cells derived exosomes and biomaterials to modulate autophagy and mend broken hearts N Sareen, A Srivastava, KN Alagarsamy, V Lionetti, S Dhingra Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 166806, 2023 | 4 | 2023 |
| Fabrication of Smart Tantalum Carbide MXene Quantum Dots with Intrinsic Immunomodulatory Properties for Treatment of Allograft Vasculopathy (Adv. Funct. Mater. 46/2021) A Rafieerad, W Yan, KN Alagarsamy, A Srivastava, N Sareen, RC Arora, ... Advanced Functional Materials 31 (46), 2170341, 2021 | 4 | 2021 |
| Human induced pluripotent stem cell (hiPSC) line UOMi006-A derived from PBMCs of a patient with Kearns-Sayre syndrome A Srivastava, KN Alagarsamy, GL Sequiera, C Rockman-Greenberg, ... Stem Cell Research 53, 102355, 2021 | 4 | 2021 |
| Low Dose of Ti3C2 MXene Quantum Dots Mitigate SARS‐CoV‐2 Infection A Yilmazer, KN Alagarsamy, C Gokce, GY Summak, A Rafieerad, ... Small Methods 7 (8), 2300044, 2023 | 3 | 2023 |
| IMMUNOENGINEERING APPLICATION OF MXENE FOR PREVENTION OF TRANSPLANT VASCULOPATHY W Yan, A Rafieerad, K Alagarsamy, L Saleth, R Arora, S Dhingra Canadian Journal of Cardiology 38 (10), S107-S108, 2022 | 1 | 2022 |
| Immunomodulatory Titanium Carbide MXene Nanosheets for Treatment of Cardiac Allograft Vasculopathy W Yan, A Rafieerad, KN Alagarsamy, RC Arora, S Dhingra Circulation 146 (Suppl_1), A15705-A15705, 2022 | | 2022 |
| Proteasomal Degradation of TRAF2 Mediates Mitochondrial Dysfunction in Doxorubicin-Cardiomyopathy (vol 146, pg 934, 2022) KN Alagarsamy CIRCULATION 146 (15), E224-E224, 2022 | | 2022 |
Sanjiv DhingraRegenerative Medicine Program, Institute of Cardiovascular Sciences, St. Boniface General HospitalVerified email at sbrc.ca
